SCHEMBL8091118

SCHEMBL8091118

CCCCOS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6053606 0.90
SCHEMBL19227214 0.87 THRB (0.50)
SCHEMBL13666251 0.87 THRB (0.50)
SCHEMBL5574704 0.87 THRB (0.50)
SCHEMBL21066501 0.87 THRB (0.50)
SCHEMBL6654932 0.87 THRB (0.50)
SCHEMBL21165745 0.87 THRB (0.50)
SCHEMBL9333772 0.87 THRB (0.50)
SCHEMBL19431359 0.87 THRB (0.50)
SCHEMBL28105754 0.87 THRB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110018591-B Layered structure and electronic device including the same 三星电子株式会社 2023-07-28 CN disclosed
CN-110885401-B Copolymer, curable resin composition containing same, and cured product thereof 株式会社大赛璐 2023-06-13 CN disclosed
US-10864282-B2 ST-246 liquid formulations and methods SIGA TECHNOLOGIES INC. (US) 2020-12-15 US disclosed
US-20200138974-A1 ST-246 LIQUID FORMULATIONS AND METHODS SIGA TECHNOLOGIES, INC. (US) 2020-05-07 US disclosed
US-10576165-B2 ST-246 liquid formulations and methods SIGA TECHNOLOGIES INC. (US) 2020-03-03 US disclosed
US-20190038767-A1 ST-246 LIQUID FORMULATIONS AND METHODS SIGA TECHNOLOGIES, INC. (US) 2019-02-07 US disclosed
US-10124071-B2 ST-246 liquid formulations and methods SIGA TECHNOLOGIES, INC. (US) 2018-11-13 US disclosed
US-20180185514-A1 ST-246 LIQUID FORMULATIONS AND METHODS SIGA TECHNOLOGIES, INC. (US) 2018-07-05 US disclosed
US-9907859-B2 ST-246 liquid formulations and methods SIGA TECHNOLOGIES, INC. (US) 2018-03-06 US disclosed
US-20170227111-A1 ROTATION TRANSMISSION DEVICE NSK LTD (JP) 2017-08-10 US disclosed
US-6160124-A Method for treating or preventing arteriosclerosis JAPAN TOBACCO INC. (JP) 2000-12-12 US disclosed
US-6057343-A HAVE SUPERIOR HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIONS AND ARE USEFUL FOR THE TREATMENT OF DIABETES AND THE COMPLICATIONS THEREOF, AS WELL AS THERAPEUTIC AGENTS FOR RELATED DISEASES SUCH AS HYPERLIPIDEMIA JAPAN TOBACCO, INC. (JP) 2000-05-02 US disclosed
US-6037359-A ARTERIOSCLEROSIS PREVENTION; ANTIDIABETIC AGENTS; ANTILIPEMIC AND HYPOGLYCEMIC AGENTS JAPAN TOBACCO, INC. (JP) 2000-03-14 US disclosed
CN-1044815-C Transparent filling agent of ordinary temp. solidification ZHAN YI (CN) 1999-08-25 CN disclosed
US-5939445-A ISOXAZOLIDINEDIONES COMPOUNDS AS HYPOGLYCEMIC AGENTS AND TREATMENT OF ARTERIOSCLEROSIS JAPAN TOBACCO, INC. (JP) 1999-08-17 US disclosed
US-5728720-A HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; TREATMENT OF DIABETES JAPAN TOBACCO INC. (JP) 1998-03-17 US disclosed
CN-1174207-A Preparation of low-viscosity, aqueous polymer dispersions having polymer volume conventiations of at least 50% by volume BASF AG (DE) 1998-02-25 CN disclosed
CN-1114328-A Transparent filling agent of ordinary temp. solidification ZHAN YI (CN) 1996-01-03 CN disclosed
EP-0684242-A1 ISOXAZOLIDINEDIONE DERIVATIVE AND USE THEREOF JAPAN TOBACCO INC. (JP) 1995-11-29 EP disclosed
EP-0603419-A1 NOVEL THIAZOLIDINEDIONE COMPOUND AND USE THEREOF Japan Tobacco Inc. (JP) 1994-06-29 EP disclosed